Belgian pharmaceutical developer UCB plans to develop a $2 billion manufacturing campus near Atlanta, representing its first U.S. plant and a major win for an ambitious mixed-use development that has been in the works for years.
Belgian drug developer picks Georgia for $2 billion investment
UCB's plans for first US manufacturing plant mark major win for ambitious mixed-use project near Atlanta
By Andy Peters
CoStar NewsMarch 25, 2026 | 8:25 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- UCB
Manufacturing
- Gwinnett County Government
Professional, Scientific, and Technical Services